24 Oct WARF announces 2025 support for UW-Madison research
The Wisconsin Alumni Research Foundation has announced $159.8 million of total support in the academic year ending in 2025 for University of Wisconsin-Madison research....
News
24 Oct RISE-AI gets $15 million boost from the Wisconsin Alumni Research Foundation
The Wisconsin Alumni Research Foundation (WARF) will commit $15 million over the next three years to extend the University of Wisconsin–Madison’s strength in artificial intelligence research and education by supporting the university’s Research, Innovation and Scholarly Excellence Initiative (RISE) focus on AI....
22 Oct What experts say about taking psilocybin as an alternative treatment for depression
The stakes are high for psilocybin clinical trials — there’s a pressing need for a more effective medical solution in the fight against depression, especially treatment-resistant depression....
21 Oct RSV research at UW-Madison could lead to new drugs, vaccines
New images of a respiratory virus that hospitalizes thousands of people in the United States each year could help develop more vaccines and other treatments, according to researchers at the University of Wisconsin-Madison....
21 Oct Informed Consent, Inclusion Prioritized in Revised Ethics for Human Trials
World Medical Association releases "Declaration of Helsinki" principles for medical research....
21 Oct Brain scans begin for nationwide Alzheimer’s disease study
Research participants have begun volunteering for brain scans at the University of Wisconsin School of Medicine and Public Health in Madison for a national study on Alzheimer’s disease and related dementias....
20 Oct Can sharks cure cancer? UW-Madison research shows positive advancements
Sharks don’t usually come to mind when you think of saving lives. But at the University of Wisconsin-Madison, students and faculty are learning from sharks everyday which is leading to advancements in cancer research....
17 Oct Injectable drug to ease advanced Parkinson’s disease symptoms approved by FDA
The drug is a 24-hour infusion injected below the skin that treats motor fluctuations in patients with advanced Parkinsons....
16 Oct Responsible Use Of AI In Healthcare: Work In Progress
Artificial Intelligence (AI) is on the cusp of quickly becoming a large component of the healthcare industry (broadly defined), with the emergence of generative AI and sophisticated predictive models making significant inroads across various domains....
16 Oct Decentralized clinical trials back in the spotlight thanks to new FDA guidance
Two experts on regulatory and compliance trends weigh in on the FDA's recently issued guidance on decentralized clinical trials....